Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma
Authors:
- Amanda EustaceAEAmanda Eustace
- Shalini PatiarSPShalini Patiar
- Helen R. ValentineHVHelen R. Valentine
- Joely IrlamJIJoely Irlam
- Anassuya RamachandranARAnassuya Ramachandran
- Ashirwad MerveAMAshirwad Merve
- Jarrod J. HomerJHJarrod J. Homer
- Carla Möller-LevetCMCarla Möller-Levet
- Francesca M. BuffaFBFrancesca M. Buffa
- Gillian HallGHGillian Hall
- Crispin J. MillerCMCrispin J. Miller
- 1 January 2013
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 49 (1) , 156-165
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Accelerated Radiotherapy With Carbogen and Nicotinamide for Laryngeal Cancer: Results of a Phase III Randomized TrialJournal of Clinical Oncology, 2012
- Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III TrialClinical Cancer Research, 2012
- Perfusion Estimated With Rapid Dynamic Contrast-Enhanced Magnetic Resonance Imaging Correlates Inversely With Vascular Endothelial Growth Factor Expression and Pimonidazole Staining in Head-and-Neck Cancer: A Pilot StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Hypoxia in larynx carcinomas assessed by pimonidazole binding and the value of CA-IX and vascularity as surrogate markers of hypoxiaEuropean Journal of Cancer, 2009
- Molecular aspects of tumour hypoxiaMolecular Oncology, 2008
- Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: An evaluation of the DAHANCA 5 studyRadiotherapy and Oncology, 2007
- Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02Journal of Clinical Oncology, 2006
- Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trialThe Lancet Oncology, 2005
- Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center studyRadiotherapy and Oncology, 2005
- Hypoxia-Inducible Factor 1α Expression as an Intrinsic Marker of HypoxiaClinical Cancer Research, 2004